Renaissance Technologies LLC Sells 8,300 Shares of Relx Plc (NYSE:RELX)

Renaissance Technologies LLC lessened its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 0.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,319,900 shares of the technology company's stock after selling 8,300 shares during the period. Renaissance Technologies LLC owned about 0.07% of Relx worth $59,950,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the business. Charles Schwab Investment Management Inc. grew its position in Relx by 13.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company's stock worth $5,709,000 after buying an additional 14,088 shares in the last quarter. Verition Fund Management LLC acquired a new stake in shares of Relx during the 3rd quarter worth $255,000. HighTower Advisors LLC increased its position in shares of Relx by 5.9% in the third quarter. HighTower Advisors LLC now owns 113,081 shares of the technology company's stock worth $5,373,000 after purchasing an additional 6,298 shares during the period. XTX Topco Ltd acquired a new position in Relx in the third quarter valued at about $397,000. Finally, MML Investors Services LLC lifted its position in Relx by 2.2% during the third quarter. MML Investors Services LLC now owns 112,812 shares of the technology company's stock worth $5,354,000 after purchasing an additional 2,395 shares during the period. 15.02% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on RELX shares. Redburn Atlantic initiated coverage on shares of Relx in a report on Wednesday, January 8th. They set a "buy" rating for the company. The Goldman Sachs Group initiated coverage on Relx in a research note on Wednesday, March 26th. They issued a "buy" rating on the stock. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, StockNews.com cut Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy".

Remove Ads

Relx Price Performance

Shares of NYSE RELX traded up $0.88 during midday trading on Monday, reaching $50.00. 651,675 shares of the company were exchanged, compared to its average volume of 724,322. Relx Plc has a one year low of $40.25 and a one year high of $51.99. The stock has a market cap of $92.54 billion, a P/E ratio of 26.88, a PEG ratio of 2.73 and a beta of 0.84. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock's 50-day moving average price is $49.29 and its 200-day moving average price is $47.87.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a boost from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is presently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.